Report Details

Global Biodegradable Drug Eluting Stents Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

ID : 7745285
Date : May 2019
Pages : 210 Pages
Industry : Pharmaceutical and Healthcare


Drug-eluting stents are peripheral or coronary stents placed into narrowed peripheral or coronary arteries that slowly release the drug to block cell proliferation. Generally, these devices are made up of metal and remain permanently or removed through further surgery. Metal stents present drawbacks such as the predisposition to late stent thrombosis, impairment of imaging with multislice CT, hindrance of surgical revascularization. Biodegradable drug-eluting stents are made up of material that dissolves or absorbed in the body, these are temporary, and no need for further surgery to removal of the stent. These are also called as bioresorbable stents or naturally- dissolving stents.



Biodegradable Drug Eluting Stents Market growth is driven by growing prevalence of coronary artery diseases, increased geriatric population who are more prone to heart diseases. According to World Health Organization WHO, cardiovascular diseases are a primary cause of deaths globally, an estimated 17.7 Mn people died from cardiovascular diseases in 2015, representing 31% of all global deaths. Of these deaths, an estimated 7.4 Mn were due to coronary heart disease and 6.7 million were due to heart stroke. Furthermore, biodegradable drug-eluting stents have various advantages over the traditional metal stents such as no need of further surgery to remove stent, quick restoration of blood flow and faster healing process which are expected to boost the biodegradable drug eluting stents market. However, a risk of complications in use and lower awareness about biodegradable stents among healthcare professionals in developing and developed regions are expected to hamper the growth of Biodegradable Drug Eluting Stents Market over the forecast period.



Biodegradable Drug Eluting Stents Market has been segmented by application, type of material and end user



Based on type of material, Biodegradable Drug Eluting Stents Market segmented into

Metallic Alloy Stents
Polymeric Stents


Based on application, Biodegradable Drug Eluting Stents Market segmented into

Coronary Artery Disease
Peripheral Artery Disease


Based on end-user, Biodegradable Drug Eluting Stents Market segmented into

Hospitals
Cardiac Centers


Biodegradable Drug Eluting Stents Market is expected to grow at notable CAGR during forecasting period. Market players are focusing on product development with extensive R&D, partnerships, and collaborations. For instance, in March 2014, Terumo Medical Corporation partnered with Arterial Remodeling Technologies to develop bioresorbable stents with the help of Arterial Remodeling Technologies. Larger players, such as Abbott and Biosensors International, are developing innovative biodegradable stents to reduce the complications post-percutaneous coronary intervention procedures. The application segments coronary artery segment expected to account for major market share as eluting stents are considered as ideal for treating coronary artery disease.



Geographically biodegradable drug eluting stents market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In North America, U.S. represents the largest market owing to the higher prevalence of cardiovascular diseases especially coronary artery diseases. Asia Pacific region is expected to register significant growth rate due to increasing awareness about biodegradable drug eluting stents in this region. In Asia region, India, China, Japan are expected to grow at significant rate owing to rise in prevalence of chronic diseases, such as diabetes and cardiac diseases which are expected to boost the demand for biodegradable drug eluting stents over the forecast period.



Some of the players in biodegradable drug eluting stents market include Biosensors International Group Singapore, Abbott Laboratories U.S, Medtronic U.S., B. Braun Holding GmbH & Co. KG B.Braun Melsungen Germany, Boston Scientific Corporation U.S., and Terumo Corporation Japan to name a few.



 

In October 2015, Boston Scientific Corporation received U.S. Food and Drug Administration FDA approval for the synergy bioabsorbable Polymer Drug-Eluting Stent System BP-DES for the treatment of coronary artery disease.


Report Outline:



The report provides granular level information about the market size, regional market share and forecast from 2019-2025
The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments and startup’s details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. Executive summary
2. Global Biodegradable Drug Eluting Stents Market Introduction
2.1. Global Biodegradable Drug Eluting Stents Market– Taxonomy
2.2. Global Biodegradable Drug Eluting Stents Market–Definitions
2.2.1. Material Type
2.2.2. Application
3. Global Biodegradable Drug Eluting Stents Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Biodegradable Drug Eluting Stents Market Dynamics – Factors Impact Analysis
3.6. Global Biodegradable Drug Eluting Stents Market– Recent Market Introductions
4. Global Biodegradable Drug Eluting Stents Market Analysis, 2014 - 2018 and Forecast, 2019 – 2025
4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
4.2. Year-over-Year Y-o-Y Growth Analysis %
4.3. Market Oppurtunity Analysis
5. Global Biodegradable Drug Eluting Stents Market Forecast, By Material Type, 2014 - 2018 and Forecast, 2019 - 2025
5.1. Metallic Alloy Stents
5.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.1.3. Market Opportunity Analysis
5.2. Polymeric Stents
5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.2.3. Market Opportunity Analysis
6. Global Biodegradable Drug Eluting Stents Market Forecast, By Application, 2014 - 2018 and Forecast, 2019 - 2025
6.1. Coronary Artery Disease
6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.1.3. Market Opportunity Analysis
6.2. Peripheral Artery Disease
6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.2.3. Market Opportunity Analysis
7. Global Biodegradable Drug Eluting Stents Market Forecast, By End User, 2014 - 2018 and Forecast, 2019 - 2025
7.1. Hospitals
7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.1.3. Market Opportunity Analysis
7.2. Cardiac Centers
7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.2.3. Market Opportunity Analysis
8. Global Biodegradable Drug Eluting Stents Market Forecast, By Region, 2014 - 2018 and Forecast, 2019 - 2025
8.1. North America
8.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.5.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.5.3. Market Opportunity Analysis
8.6. Global Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By End User, and Region, 2019 – 2025
9. North America Biodegradable Drug Eluting Stents Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
9.1.1. Material Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
9.1.1.1. Metallic Alloy Stents
9.1.1.2. Polymeric Stents
9.1.2. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
9.1.2.1. Coronary Artery Disease
9.1.2.2. Peripheral Artery Disease
9.1.3. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
9.1.3.1. Hospitals
9.1.3.2. Cardiac Centers
9.1.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn Y-o-Y Growth % and Market Share %
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By End User, and Country, 2019 – 2025
9.1.6. North America Biodegradable Drug Eluting Stents Market Dynamics – Trends
10. Europe Biodegradable Drug Eluting Stents Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
10.1.1. Material Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.1.1. Metallic Alloy Stents
10.1.1.2. Polymeric Stents
10.1.2. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.2.1. Coronary Artery Disease
10.1.2.2. Peripheral Artery Disease
10.1.3. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.3.1. Hospitals
10.1.3.2. Cardiac Centers
10.1.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By Harvesting, By End User, and Country, 2019 – 2025
10.1.6. Europe Biodegradable Drug Eluting Stents Market Dynamics – Trends
11. Asia-Pacific Biodegradable Drug Eluting Stents Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
11.1.1. Material Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.1.1. Metallic Alloy Stents
11.1.1.2. Polymeric Stents
11.1.2. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.2.1. Coronary Artery Disease
11.1.2.2. Peripheral Artery Disease
11.1.3. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.3.1. Hospitals
11.1.3.2. Cardiac Centers
11.1.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn,
Y-o-Y Growth %, and Market Share %
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By Harvesting, By End User, and Country, 2019 – 2025
11.1.6. Asia-Pacific Biodegradable Drug Eluting Stents Market Dynamics – Trends
12. Latin America Biodegradable Drug Eluting Stents Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.1.1. Material Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.1.1. Metallic Alloy Stents
12.1.1.2. Polymeric Stents
12.1.2. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.2.1. Coronary Artery Disease
12.1.2.2. Peripheral Artery Disease
12.1.3. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.3.1. Hospitals
12.1.3.2. Cardiac Centers
12.1.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By Harvesting, End User, and Country, 2019 – 2025
12.1.6. Latin America Biodegradable Drug Eluting Stents Market Dynamics – Trends
13. Middle East & Africa Biodegradable Drug Eluting Stents Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
13.1.1. Material Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.1.1. Metallic Alloy Stents
13.1.1.2. Polymeric Stents
13.1.2. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.2.1. Coronary Artery Disease
13.1.2.2. Peripheral Artery Disease
13.1.3. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.3.1. Hospitals
13.1.3.2. Cardiac Centers
13.1.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth %, and Market Share %
13.1.4.1. Gulf Cooperation Council GCC Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By Harvesting, By End User, and Country, 2019 – 2025
13.1.6. MEA Biodegradable Drug Eluting Stents Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis
14.2.1. Biosensors International Group Singapore
14.2.2. Abbott Laboratories U.S
14.2.3. Medtronic U.S.
14.2.4. B. Braun Holding GmbH & Co. KG B.Braun Melsungen Germany
14.2.5. Boston Scientific Corporation U.S.
14.2.6. Terumo Corporation Japan
15. Research Methodology
16. Key Assumptions and Acronyms


Please fill the following form to know more details about this Report




RELATED PRODUCTS



CHOOSE A FORMAT


  •  Single User Price : $ 4400
  •  Enterprise User License : $ 6600
  •  Corporate User License : $ 8900

Have A Question ?


  DOWNLOAD SAMPLE



TESTIMONIALS

I am completely satisfied with the information given in the sample pages of the report and I am waiting for the affirmative response from my peers and colleagues to purchase it.hey answered to all my queries promptly. I am highly satisfied!!
John Keats
We received a very quick response to all our queries on the RTLS report and we were also given a free consult with analyst for 15 minutes. It is refreshing (and increasingly rare) to have a new company go the extra mile to win the confidence of the customer
Ernest Hemingway
I would like to express my gratitude for the excellent service received this morning from the support team. They acknowledged my concern of adding me to the secondary user's list immediately. Thank you for this excellent, speedy and thoughtful service
Jacob Watson

CUSTOM RESEARCH

Still haven't found what you're looking for ?
Speak to our Custom Research Team